5AM Ventures
5AM Ventures is a privately-held life science venture capital firm founded in 2002 that finances and builds early-stage therapeutics companies, operating $750M across a Series A-focused venture fund, a public/later-stage opportunities fund, and the 4:59 Initiative incubator.
- Company typePrivate
- Founded2002
- HeadquartersMenlo Park, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What 5AM Ventures does
5AM Ventures is a privately-held life science venture capital firm founded in 2002 that finances and builds next-generation therapeutics, drug delivery technologies, and life science instrument companies. The firm operates three distinct vehicles: the flagship 5AM Ventures fund (Series A-focused private therapeutics investing, currently in its seventh vintage at $450M); 5AM Opportunities, a public equities strategy investing in small and mid-cap public and later-stage private biotech (currently $300M in its second vintage); and the 4:59 Initiative, an internal incubator that partners alongside academics and entrepreneurs to generate proof-of-concept data that enables Series A financings. The firm is organized as 5AM Venture Management, LLC, a Delaware-domiciled registered investment adviser, and maintains offices in San Francisco, California and Boston, Massachusetts.
5AM Ventures firmographics
Firmographics- Name
- 5AM Ventures
- Legal name
- 5AM Venture Management, LLC
- Website
- http://www.5amventures.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- 5AM Ventures is a privately-held life science venture capital firm founded in 2002 that finances and builds early-stage therapeutics companies, operating $750M across a Series A-focused venture fund, a public/later-stage opportunities fund, and the 4:59 Initiative incubator.
- Ownership category
- akta.pro rank
5AM Ventures industry classification
Industry- Product category
- Venture Capital - Life Sciences
- NAICS
- Funds, Trusts, and Other Financial Vehicles (525), Other Investment Pools and Funds (5259)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
- akta.pro secondary industries
- Healthcare & Life Sciences Growth Equity (FSANACAB), Early-Stage Venture Capital (Series A/B) (FSANAAAB)
Keywords
Where 5AM Ventures is headquartered
LocationHeadquarters
- HQ city
- Menlo Park
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
5AM Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Venture Capital Management Fees and Carried Interest: 5AM Ventures generates returns through management fees charged on committed capital across its funds (5AM Ventures VII at $450M and 5AM Opportunities II at $300M as of January 2025), and carried interest (performance fees) on successful exits of portfolio companies. Fund data as of January 1, 2025 shows $450M under management for the latest venture fund and $300M for the opportunities fund.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Venture Capital Fund Investment (by institution/qualified investor) |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
5AM Ventures product offering
Product offeringCore offering
5AM Ventures is a life science venture capital firm that finances and builds next-generation life sciences companies. The firm deploys capital through three strategies: the 5AM Ventures venture capital fund (Series A-focused private therapeutic companies), the 5AM Opportunities public equity strategy (small/mid-cap public and later-stage private biotech), and the 4:59 Initiative, an internal incubator that partners alongside academics and entrepreneurs to establish proof-of-concept data enabling Series A financing.
Product overview
5AM Ventures is a life science venture capital firm offering two primary investment strategies: (1) 5AM Ventures, its core venture capital fund focused on early-stage private therapeutic companies with emphasis on Series A financing, and (2) 5AM Opportunities, its public equity strategy investing in small and mid-cap public and later-stage private biotech companies. Additionally, the firm operates the 4:59 Initiative, an internal incubation effort that partners with academics and entrepreneurs to develop proof-of-concept data for breakthrough science prior to Series A funding. The firm currently manages $450M from 5AM Ventures VII and $300M from 5AM Opportunities II.
Differentiator
Problem solved
Functional benefit
Brands
- 4:59 Initiative: 5AM's hands-on internal effort to discover, incubate, and fund breakthrough science, partnering alongside academics and entrepreneurs to establish proof-of-concept data for Series A financing.
- 5AM Ventures VII
- 5AM Opportunities II
Products and services
- 5AM Ventures VII Venture capital fund for institutional and qualified investors that invests in private therapeutic companies, typically early-stage with emphasis on Series A financing. Currently investing $450M across biopharmaceuticals, drug delivery technologies, and life science instruments.
- 5AM Opportunities II Public equity strategy fund for institutional and qualified investors that invests in small and mid-cap public and later-stage private biotech and life science companies, complementing the venture capital strategy.
- 4:59 Initiative Internal incubator program for academics and entrepreneurs developing breakthrough science. Partners alongside founders to establish proof-of-concept data that enables Series A financing, often serving as an extension of the operating team.
Quantifiable outcome
- Over 90,000 patients enrolled across 450+ clinical trial sites by portfolio companies
- +1 more outcomes
Companies that use 5AM Ventures
Customer profileSegments1 record
Ideal customer profiles2 records
5AM Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
5AM Ventures partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights6 records
5AM Ventures competitors and assessment
Company assessmentDirect peers
- Atlas Venture: Early-stage life sciences venture firm based in Boston that builds biotech companies from inception through Series A. Atlas Venture is one of the closest comparables to 5AM given similar size, sector focus, and company-formation approach.
- Third Rock Ventures: Boston-based life sciences VC that focuses on company formation and building therapeutic platforms from inception. Closely comparable to 5AM's 4:59 Initiative model and Series A emphasis.
- ARCH Venture Partners: Large early-stage life sciences and technology venture firm that co-invests alongside 5AM in deals such as Prolynx and Mendra. ARCH is comparable as a sector-focused specialist with multi-fund platform and incubation capabilities.
- OrbiMed: Healthcare-dedicated investment firm across private equity, venture, and public equities. OrbiMed is a frequent co-investor with 5AM (Prolynx, Mendra) and operates a similar dual-strategy venture and public opportunities platform.
- Flagship Pioneering: Cambridge-based life sciences company-formation firm that incubates and builds biotech platforms from inception. Highly comparable to 5AM's hands-on 4:59 Initiative incubation model.
- RA Capital Management: Crossover healthcare investment manager with both private and public biotech exposure. RA Capital competes with 5AM Opportunities II in the public/small-cap biotech arena and participates in private crossover rounds.
- Frazier Life Sciences: Healthcare-focused venture firm investing across therapeutics, medical devices, and diagnostics. Comparable as a sector specialist of similar scale with public/private strategies.
- Lux Capital: Technology and life sciences venture firm that co-invested in Mendra alongside 5AM. Lux's growing biotech practice overlaps with 5AM's therapeutic focus.
- 8VC: Technology and biotech venture firm that co-led Mendra's Series A alongside 5AM. 8VC's increasing life sciences practice makes it a comparable newer entrant in healthcare VC.
Broad incumbents
- New Enterprise Associates (NEA): Large multi-stage venture firm with a dedicated healthcare practice. Comparable to 5AM as a generalist with significant life sciences exposure, though NEA's broader sector mandate makes it a broad incumbent rather than a specialist.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
5AM Ventures social profiles
Digital presence5AM Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
5AM Ventures leadership team
Management profileNumber of profiles
Profiles10 records
5AM Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
5AM Ventures M&A and investment
M&A and investmentM&A
Investments219 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 5AM Ventures
What does 5AM Ventures do?
5AM Ventures is a life science venture capital firm that finances and builds next-generation life sciences companies. The firm deploys capital through three strategies: the 5AM Ventures venture capital fund (Series A-focused private therapeutic companies), the 5AM Opportunities public equity strategy (small/mid-cap public and later-stage private biotech), and the 4:59 Initiative, an internal incubator that partners alongside academics and entrepreneurs to establish proof-of-concept data enabling Series A financing.
Is 5AM Ventures a public or private company?
5AM Ventures is a private company. It is classified as management employee owned and is currently operating.
When was 5AM Ventures founded?
5AM Ventures was founded in 2002. It employs 11 to 50 people.
Where is 5AM Ventures based?
5AM Ventures is headquartered in Menlo Park, United States, in the North America region.
How does 5AM Ventures make money?
One revenue line is on record: venture Capital Management Fees and Carried Interest.
Who are 5AM Ventures's main competitors?
Direct peers on record are Atlas Venture, Third Rock Ventures, ARCH Venture Partners, OrbiMed, Flagship Pioneering, RA Capital Management, Frazier Life Sciences, Lux Capital and 8VC. New Enterprise Associates (NEA) is listed as a broad incumbent.
Does 5AM Ventures have an API?
No public API is recorded for 5AM Ventures.
What industry is 5AM Ventures in?
5AM Ventures's product category is Venture Capital - Life Sciences. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 525 and its SIC code is 6282.